» Articles » PMID: 35927303

Phosphorylation of OTUB1 at Tyr 26 Stabilizes the MTORC1 Component, Raptor

Overview
Specialty Cell Biology
Date 2022 Aug 4
PMID 35927303
Authors
Affiliations
Soon will be listed here.
Abstract

Raptor plays a critical role in mTORC1 signaling. High expression of Raptor is associated with resistance of cancer cells to PI3K/mTOR inhibitors. Here, we found that OTUB1-stabilized Raptor in a non-canonical manner. Using biochemical assays, we found that the tyrosine 26 residue (Y26) of OTUB1 played a critical role in the interaction between OTUB1 and Raptor. Furthermore, non-receptor tyrosine kinases (Src and SRMS kinases) induced phosphorylation of OTUB1 at Y26, which stabilized Raptor. Interestingly, phosphorylation of OTUB1 at Y26 did not affect the stability of other OTUB1-targeted substrates. However, dephosphorylation of OTUB1 destabilized Raptor and sensitized cancer cells to anti-cancer drugs via mitochondrial reactive oxygen species-mediated mitochondrial dysfunction. Furthermore, we detected high levels of phospho-OTUB1 and Raptor in samples of patients with renal clear carcinoma. Our results suggested that regulation of OTUB1 phosphorylation may be an effective and selective therapeutic target for treating cancers via down-regulation of Raptor.

Citing Articles

USP9X-mediated deubiquitination of Raptor contributes to autophagy impairment and memory deficits in P301S mice.

Zheng S, Zhu J, Wang C, Wu Y, Sun S, Guo H Cell Commun Signal. 2024; 22(1):516.

PMID: 39449082 PMC: 11515493. DOI: 10.1186/s12964-024-01872-8.


Non-canonical deubiquitination of OTUB1 induces IFNγ-mediated cell cycle arrest via regulation of p27 stability.

Lee S, Woo S, Seo S, Lee H, Kim S, Chang Y Oncogene. 2024; 43(24):1852-1860.

PMID: 38664499 PMC: 11164677. DOI: 10.1038/s41388-024-03042-z.


OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination.

Peng L, Wu T, Liu Y, Zhao D, He W, Yuan Y Cell Oncol (Dordr). 2024; 47(3):987-1004.

PMID: 38315284 PMC: 11219430. DOI: 10.1007/s13402-023-00913-7.


OTUB1-mediated inhibition of ubiquitination: a growing list of effectors, multiplex mechanisms, and versatile functions.

Wu M, Sun L, Song T Front Mol Biosci. 2024; 10:1261273.

PMID: 38264570 PMC: 10803509. DOI: 10.3389/fmolb.2023.1261273.


Phosphorylation of USP27X by GSK3β maintains the stability and oncogenic functions of CBX2.

Xing Y, Ba-Tu J, Dong C, Cao X, Li B, Jia X Cell Death Dis. 2023; 14(11):782.

PMID: 38030604 PMC: 10687032. DOI: 10.1038/s41419-023-06304-y.


References
1.
Edelmann M, Kramer H, Altun M, Kessler B . Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion. FEBS J. 2010; 277(11):2515-30. DOI: 10.1111/j.1742-4658.2010.07665.x. View

2.
Kamba T, McDonald D . Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer. 2007; 96(12):1788-95. PMC: 2359962. DOI: 10.1038/sj.bjc.6603813. View

3.
Qayyum T, McArdle P, Lamb G, Jordan F, Orange C, Seywright M . Expression and prognostic significance of Src family members in renal clear cell carcinoma. Br J Cancer. 2012; 107(5):856-63. PMC: 3426751. DOI: 10.1038/bjc.2012.314. View

4.
Wang T, Zhang W, Wang Z, Wu Z, Du B, Li L . RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1. Cancer Med. 2019; 9(4):1529-1543. PMC: 7013072. DOI: 10.1002/cam4.2810. View

5.
Xu J, Pham C, Albanese S, Dong Y, Oyama T, Lee C . Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. J Clin Invest. 2016; 126(9):3526-40. PMC: 5004947. DOI: 10.1172/JCI86120. View